S R Biohealth Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 20-12-2024
- Paid Up Capital ₹ 0.99 M
as on 20-12-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.40 Cr
as on 20-12-2024
- Satisfied Charges ₹ 10.03 Cr
as on 20-12-2024
- Revenue -6.08%
(FY 2021)
- Profit 77.03%
(FY 2021)
- Ebitda 78.36%
(FY 2021)
- Net Worth 15.94%
(FY 2021)
- Total Assets 47.03%
(FY 2021)
About S R Biohealth
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.99 M.
The company currently has active open charges totaling ₹3.40 Cr. The company has closed loans amounting to ₹10.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krishna Vashishtha and Devendra Vashishtha serve as directors at the Company.
- CIN/LLPIN
U51397DL2003PTC123088
- Company No.
123088
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does S R Biohealth Private Limited offer?
S R Biohealth Private Limited offers a wide range of products and services, including Pulse Oximeter, Glucometer & POCT Devices, Glucometer, Electrodiagnostic Instruments, Medical Diagnostic Equipment, Surgical Light, LED OT Lights, Blood Bank Equipments, Blood Bag Tube Sealer, Ceiling OT Lights, Blood Collection Monitor.
Who are the key members and board of directors at S R Biohealth?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Vashishtha  | Director | 14-Jan-2011 | Current |
| Devendra Vashishtha | Director | 14-Sep-2003 | Current |
Financial Performance of S R Biohealth.
S R Biohealth Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 6.08% decrease. The company also saw a substantial improvement in profitability, with a 77.03% increase in profit. The company's net worth Soared by an impressive increase of 15.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of S R Biohealth?
In 2021, S R Biohealth had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Jun 2023 | ₹3.00 Cr | Open |
Hdfc Bank Limited Creation Date: 31 Oct 2020 | ₹4.00 M | Open |
Hdfc Bank Limited Creation Date: 09 Mar 2017 | ₹2.50 Cr | Satisfied |
How Many Employees Work at S R Biohealth?
Unlock and access historical data on people associated with S R Biohealth, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S R Biohealth, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S R Biohealth's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
